Skip to main content
. 2016 Aug 11;9:51–65. doi: 10.4137/IJTR.S38190

Table 1.

Effects of acute administration of various doses of KA on concentrations of some kynurenine metabolites in rat liver and serum.

DOSE OF KA (mg/kg) 3-HK 3-HAA KA AA
0 Liver 2.86 ± 0.68 0.10 ± 0.01 0.07 ± 0.02 0.16 ±0.06
Serum 3.79 ± 0.32 0.95 ± 0.12 0.85 ± 0.18 UD
1 Liver 3.47 ± 0.65 0.18 ± 0.06 28.1 ± 1.2* 0.53 ±0.21
Serum 3.46 ± 0.27 0.75 ± 0.08 3.20 ± 0.59* (0.05, 0.41)
2.5 Liver 18.6 ± 1.0* 1.13 ± 0.32* 30.6 ± 0.8* 0.27 ± 0.14
Serum 4.87 ± 0.32* 0.61 ± 0.09 3.28 ± 0.09* UD
5 Liver 11.6 ± 3.9* 1.67 ± 0.74 35.1 ± 5.2* 0.89 ± 0.54
Serum 3.55 ± 0.44 0.81 ± 0.18 4.01 ± 0.45* (0.10, 0.01)
7.5 Liver 16.0 ± 1.0* 1.62 ± 0.74 37.4 ± 18.8* 1.01 ± 0.35*
Serum 4.59 ± 0.47 0.61 ± 0.13 11.2 ± 0.2* (0.24)
10 Liver 18.8 ± 0.1* 0.84 ± 0.25* 54.5 ± 9.6* 0.39 ± 0.11
Serum 4.90 ± 0.43 0.52 ± 0.06 26.4 ± 1.4* (0.01, 0.19)

Notes: Rats were given an intraperitoneal injection of various doses of KA or physiological saline and were killed one hour later. Values are mean ± SEM for each group of five rats, except for individual values in parentheses. The significance of the differences from the zero dose control group is indicated by an asterisk (*) (P = 0.042–0.001 by t-test).